Congress Trades

Latest disclosures

Chamber Transaction Date Member Owner Asset Action ▲ Amount Ticker Δ Since Trade View
Senate Apr. 3, 2023 Tommy Tuberville Joint Regeneron Pharmaceuticals, Inc. - Common Stock PURCHASE $1,001 - $15,000 REGN ▼ -17.08% View
Senate Mar. 29, 2021 Tommy Tuberville Joint Regeneron Pharmaceuticals, Inc. PURCHASE $1,001 - $15,000 REGN ▲ +42.28% View
House Aug. 11, 2023 Greg Landsman Spouse Regeneron Pharmaceuticals, Inc. - Common Stock PURCHASE $1,001 - $15,000 REGN ▼ -15.10% View
House Jan. 15, 2025 Julie Johnson Joint Regeneron Pharmaceuticals Inc PURCHASE $1,001 - $15,000 REGN ▼ -2.61% View
House May. 15, 2025 Robert P. Bresnahan Regeneron Pharmaceuticals Inc PURCHASE $1,001 - $15,000 REGN ▲ +17.11% View
House Sep. 9, 2024 Ro Khanna Spouse Regeneron Pharmaceuticals Inc PURCHASE $1,001 - $15,000 REGN ▼ -40.15% View
Senate Apr. 3, 2023 Tommy Tuberville Joint Regeneron Pharmaceuticals, Inc. - Common Stock PURCHASE $1,001 - $15,000 REGN ▼ -17.08% View
House Jan. 24, 2025 Josh Gottheimer Joint Regeneron Pharmaceuticals Inc SALE $1,001 - $15,000 REGN ▲ +1.38% View
House Nov. 1, 2024 Jonathan L. Jackson Joint Regeneron Pharmaceuticals Inc SALE $1,001 - $15,000 REGN ▼ -18.79% View
House Apr. 10, 2025 Byron Donalds Spouse Regeneron Pharmaceuticals Inc SALE $1,001 - $15,000 REGN ▲ +25.39% View
House Feb. 12, 2025 Julie Johnson Joint Regeneron Pharmaceuticals Inc SALE $1,001 - $15,000 REGN ▲ +3.20% View
House Nov. 13, 2024 Jonathan L. Jackson Joint Regeneron Pharmaceuticals Inc SALE $15,001 - $50,000 REGN ▼ -14.82% View
House Feb. 25, 2025 Robert P. Bresnahan Regeneron Pharmaceuticals Inc SALE $1,001 - $15,000 REGN ▼ -5.30% View
House Oct. 15, 2024 Greg Landsman Spouse Regeneron Pharmaceuticals Inc SALE $1,001 - $15,000 REGN ▼ -32.60% View
House Oct. 23, 2024 Josh Gottheimer Joint Regeneron Pharmaceuticals Inc SALE $1,001 - $15,000 REGN ▼ -27.23% View
Senate Apr. 4, 2024 Tommy Tuberville Joint Regeneron Pharmaceuticals, Inc. - Common Stock SALE (FULL) $1,001 - $15,000 REGN ▼ -26.89% View
Senate Mar. 30, 2022 Tommy Tuberville Joint Regeneron Pharmaceuticals, Inc. - Common Stock SALE (FULL) $1,001 - $15,000 REGN ▼ -1.05% View
House Apr. 8, 2025 Robert P. Bresnahan Regeneron Pharmaceuticals, Inc. - Common Stock SALE (FULL) $1,001 - $15,000 REGN ▲ +23.04% View
House Nov. 29, 2024 Josh Gottheimer Joint Regeneron Pharmaceuticals, Inc. - Common Stock SALE (PARTIAL) $1,001 - $15,000 REGN ▼ -8.68% View
House Jul. 1, 2024 Josh Gottheimer Joint Regeneron Pharmaceuticals, Inc. - Common Stock SALE (PARTIAL) $1,001 - $15,000 REGN ▼ -35.19% View
House Nov. 19, 2024 Josh Gottheimer Joint Regeneron Pharmaceuticals, Inc. - Common Stock SALE (PARTIAL) $1,001 - $15,000 REGN ▼ -7.99% View
Last updated: Nov 13, 14:37